Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
- 1 February 1991
- journal article
- Vol. 23, 1108-10
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- THE PATHOLOGY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS OCCURRING IN THE SETTING OF CYCLOSPORINE A-PREDNISONE IMMUNOSUPPRESSION1988
- CANCERS FOLLOWING CYCLOSPORINS THERAPYTransplantation, 1987
- POLYMORPHIC DIFFUSE B-CELL HYPERPLASIAS AND LYMPHOMAS IN RENAL-TRANSPLANT RECIPIENTS1981
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979